- Report
- August 2024
- 132 Pages
Global
From €2838EUR$2,990USD£2,394GBP
- Report
- January 2025
- 160 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- October 2024
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- January 2025
- 305 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- December 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 602 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 194 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 193 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 194 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 194 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 193 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 179 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 192 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 601 Pages
Global
From €5316EUR$5,600USD£4,484GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more